ArticleFrontiers in cell and developmental biology2025
Nodal and cripto-1: distinct functions regulate trophoblast specification in mouse pregnancy.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Serum Concentration of CRIPTO-1 in Pregnancies Complicated by Placenta Accreta Spectrum.BioMed research international · 2026Article
- Expression of Cripto-1 protein in placentas from term pregnancies with and without fetal growth restriction: a retrospective cohort study in Croatia.Obstetrics & gynecology science · 2026Article
- Cripto-1 and Cripto-3 differential expression pattern in human placenta, umbilical cord and fetal tissues suggests new functions for these proteins.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Proper placentation is essential for fetal growth and development in mammals. Nodal signaling is essential to ensure proper embryo development and requires Cripto-1 as a co-receptor. Both factors have been shown to be expressed in the maternal decidua and developing placenta. Notably, a maternal loss of either Nodal or Cripto-1 leads to defective placentation resulting in intrauterine growth restriction and fetal loss. However, the role of Nodal or Cripto-1 in placental development has not been determined. Methods: To better understand the roles of Nodal and Cripto-1 in trophoblast populations, we employed a trophoblast-specific deletion model using Tat-Cre recombinant protein to induce deletion of the floxed Nodal or Cripto-1 genes exclusively in the trophectoderm at the blastocyst stage (TE-KO). Treated embryos were then transferred into the uteri of pseudopregnant mice, and implantation sites were examined at gestational days (d) 8.5 and 10.5. Placental morphology and trophoblast populations were analyzed through histological and molecular marker analysis. Results: TE-KO of Nodal led to a decrease in the implantation site size and placental thickness, primarily due to a smaller labyrinth area while the junctional zone was increased. Immunostaining revealed an important expansion of PL Discussion: The distinct phenotypes observed indicate the different roles Nodal and Cripto-1 play in placental development. This highlights the importance of other TGF-β-dependent and independent pathways involving Cripto-1. Overall, our findings highlight the critical role of Nodal and Cripto-1 in regulating key aspects of placental development, including trophoblast differentiation, cellular specification, and structural organization, promising avenues for future research in placental biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.